FDA
approval
· 2019-07-24
FDA Approved: BAQSIMI — Original Application (Amphastar Pharmaceuticals, Inc.)
Summary
FDA approved BAQSIMI (glucagon) from Amphastar Pharmaceuticals in an Original Application for the treatment of severe hypoglycemia in people with diabetes melli…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BAQSIMI (GLUCAGON)